{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:29:28Z","timestamp":1794241768786,"version":"4.9.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Small\/Large Cell Carcinoma of the Cervix: Sisters United"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1136\/ijgc-2023-004708","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:45:14Z","timestamp":1691714714000},"page":"1359-1369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study"],"prefix":"10.1016","volume":"33","clinical-trial-number":[{"clinical-trial-number":"nct05063916","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1753-1778","authenticated-orcid":false,"given":"Gloria","family":"Salvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4533-2845","authenticated-orcid":false,"given":"Alejandra","family":"Flores Legarreta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetha","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0697-1815","authenticated-orcid":false,"given":"Anuja","family":"Jhingran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Bhosale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4467-6785","authenticated-orcid":false,"given":"Reem","family":"Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi R.","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary B.","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0810-2648","authenticated-orcid":false,"given":"Michael","family":"Frumovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2023-004708_bb0010","unstructured":"National Cancer Institute (NCI) . Rare cancer. Available: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/rare-cancer [Accessed 30 Jan 2023]."},{"key":"10.1136\/ijgc-2023-004708_bb0015","author":"WHO","year":"2018","journal-title":"Global Cancer Observatory (GLOBOCAN)"},{"key":"10.1136\/ijgc-2023-004708_bb0020","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The RedCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1136\/ijgc-2023-004708_bb0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (RedCap): a metadata-driven methodology and workflow process for providing translational research Informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1136\/ijgc-2023-004708_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Corrigendum to: revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2023-004708_bb0035","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2003.01.501","article-title":"Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy","volume":"21","author":"Hoskins","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2023-004708_bb0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ajog.2022.12.009","article-title":"Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study","volume":"228","author":"Frumovitz","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2023-004708_bb0045","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/ijgc-2019-000504","article-title":"Updates and management algorithm for neuroendocrine tumors of the uterine cervix","volume":"29","author":"Salvo","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004708_bb0050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/ijgc-2020-002213","article-title":"Role of radical hysterectomy in patients with early-stage high-grade neuroendocrine cervical carcinoma: a NeCTuR study","volume":"31","author":"Salvo","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004708_bb0055","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ygyno.2015.03.015","article-title":"Primary surgery versus primary radiation therapy for FIGO stages I-II small cell carcinoma of the uterine cervix: a retrospective Taiwanese Gynecologic Oncology Group study","volume":"137","author":"Chen","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004708_bb0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ygyno.2017.10.027","article-title":"Prognostic factors and optimal therapy for stages I-II Neuroendocrine Carcinomas of the uterine Cervix: A multi-center retrospective study","volume":"148","author":"Ishikawa","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004708_bb0065","doi-asserted-by":"crossref","first-page":"100800","DOI":"10.1016\/j.currproblcancer.2021.100800","article-title":"A real-world, population-based study of the trends for incidence and prognosis in high-grade neuroendocrine tumor of cervix","volume":"46","author":"Yang","year":"2022","journal-title":"Curr Probl Cancer"},{"key":"10.1136\/ijgc-2023-004708_bb0070","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ygyno.2022.03.022","article-title":"Definitive pelvic radiation therapy improves survival in stage IVB neuroendocrine cervical carcinoma: a NeCTuR study","volume":"165","author":"Salvo","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004708_bb0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ygyno.2019.10.033","article-title":"Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: a novel treatment strategy","volume":"156","author":"Perkins","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004708_bb0080","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/ijgc-2023-004465","article-title":"Definitive pelvic radiotherapy for patients with newly diagnosed stage IVB cervical cancer: a systematic review","volume":"33","author":"Viveros-Carre\u00f1o","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004708_bb0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ygyno.2016.10.040","article-title":"Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix","volume":"144","author":"Frumovitz","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004708_bb0090","first-page":"20","author":"NCCN guidelines","year":"2023","journal-title":"Cervical cancer - NCCN clinical practice guidelines in oncology (NCCN guidelines\u00ae). Version 12023"},{"key":"10.1136\/ijgc-2023-004708_bb0095","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ygyno.2021.04.039","article-title":"Neuroendocrine tumors of the gynecologic tract update","volume":"162","author":"Winer","year":"2021","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24016992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24016992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2023-004708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:28:40Z","timestamp":1753234120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24016992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1048891X24016992"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2023-004708","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/ijgc-2023-004708.supp1","asserted-by":"subject"}]},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2023-004708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}